Evidence map›Paper›PMID 41031175›Full record

ArticleJournal of inflammation research2025

Prolonged Acute Kidney Injury and Symmetrical Peripheral Gangrene: A Rare Case Report of Acute Promyelocytic Leukemia.

Yu-Ke Kong, Hong Shu, Wen-Jun Zhang, Chong-Yang Wu

Abstract readCase Reports
In one paragraph

Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yu-Ke Kong *Department of Nephrology, Lanzhou University Second Hospital, Lanzhou, Gansu, People's Republic of China.
Hong Shu *Department of Nephrology, Lanzhou University Second Hospital, Lanzhou, Gansu, People's Republic of China.
Wen-Jun ZhangDepartment of Nephrology, Lanzhou University Second Hospital, Lanzhou, Gansu, People's Republic of China.
Chong-Yang WuDepartment of Hematology, Lanzhou University Second Hospital, Lanzhou, Gansu, People's Republic of China.ORCID 0009-0005-5504-3627

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) is a serious complication of acute promyelocytic leukemia (APL). However, symmetric peripheral gangrene (SPG) and AKI have rarely been reported in this disease. Here we present the case of a patient who developed life-threatening APL complicated by AKI and SPG. Laboratory investigations revealed disseminated intravascular coagulation (DIC), respiratory failure, renal insufficiency, hepatic insufficiency, cardiac failure, and infection with multiple pathogens, including: novel coronavirus disease (COVID-19), candida monda, saccharomyces capitis, aspergillus fumigatus, candida lusitaniae, aspergillus flavus. One month later, the patient was off the ventilator, but his renal function needed hemodialysis. He also developed SPG, particularly the fingers of the hands and feet. After two months, the patient was discharged from hospital with normal liver and heart function. Four months after discharge, the patient's APL was on the mend, but some of the gangrenous sites had undergone autoamputation. Therefore, AKI and SPG are complex clinical complications in APL that pose significant challenges to clinicians. In addition to coagulopathy, the presence of COVID-19 and DIC worsened the clinical outcomes. At the same time, we extensively reviewed the literature to provide a comprehensive analysis of the pathogenesis and management strategies of these complications.

Indexed as

acute kidney injuryacute promyelocytic leukemiacase reportdisseminated intravascular coagulationsymmetrical peripheral gangrene

Identifiers

PMID41031175
PMCPMC12478225

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.